نتایج جستجو برای: vaccine potency

تعداد نتایج: 133954  

اژدری, سهیلا, اکبری, مینو, جزایری, سید محمد , دارم, مریم , محمودی, محمود, نوروزی, مهدی, پاکزاد, سعید رضا, کریم‌زاده بیدهندی, هادی,

Background: Hepatitis B vaccination has been included in routine immunization of all individuals according to WHO recommendations since 1991. Despite successful coverage, 3-5% of recipients fail to mount a desirable protection level of Ab. Vaccine failure results from: emergence of mutation, immune failure of individuals, decrease in vaccine potency, and etc. The quality of Hepatitis B va...

Journal: :The Journal of Experimental Medicine 1955
Ulrich Krech

The activation of poliomyelitis virus from a "neutral" virus-antibody mixture by the addition of non-infectious virus is described. The phenomenon was demonstrated in tissue cultures using both Petri dishes and roller tubes. The reaction was found to be type-specific and a relationship between antigen dilution and number of plaques counted was established. The relative potency of vaccine prepar...

Journal: :Cancer research 2005
Chao-Wei Liao Chi-An Chen Chien-Nan Lee Yi-Ning Su Ming-Cheng Chang Ming-Houg Syu Chang-Yao Hsieh Wen-Fang Cheng

Antigen-specific immunotherapy represents an attractive approach for cancer treatment because of the capacity to eradicate systemic tumors at multiple sites in the body while retaining the requisite specificity to discriminate between neoplastic and nonneoplastic cells. It has been shown that certain domains of bacterial exotoxins facilitate translocation from extracellular and vesicular compar...

Journal: :Bulletin of the World Health Organization 1996
V Dietz J B Milstien F van Loon S Cochi J Bennett

Neonatal tetanus (NT) is a major cause of mortality in developing countries, with over 400,000 deaths estimated to occur annually. WHO has adopted the goal of eliminating NT worldwide, and a major strategy for its prevention is the administration of at least two properly spaced doses of tetanus toxoid (TT) to women of childbearing age in high-risk areas to protect passively their newborns at bi...

2013
Waldely Oliveira Dias Arno A.J. van der Ark Maria Aparecida Sakauchi Flávia Saldanha Kubrusly Ana Fabíola R.O. Prestes Monamaris Marques Borges Noemi Furuyama Denise S.P.Q. Horton Wagner Quintilio Marta Antoniazi Betsy Kuipers Bernard A.M. van der Zeijst Isaias Raw

An improved whole cell pertussis vaccine, designated as Plow, which is low in endotoxicity due to a chemical extraction of lipo-oligosaccharide (LOS) from the outer membrane, was evaluated for safety, immunogenicity and potency, comparatively to a traditional whole cell pertussis vaccine. Current whole cell pertussis vaccines are effective but contain large quantities of endotoxin and consequen...

Journal: :Journal of immunology 2001
W F Cheng C F Hung C Y Chai K F Hsu L He C M Rice M Ling T C Wu

Recently, self-replicating RNA vaccines (RNA replicons) have emerged as an effective strategy for nucleic acid vaccine development. Unlike naked DNA vaccines, RNA replicons eventually cause lysis of transfected cells and therefore do not raise the concern of integration into the host genome. We evaluated the effect of linking human papillomavirus type 16 E7 as a model Ag to Mycobacterium tuberc...

2013
Stephen J. Thomas Kenneth H. Eckels Isabelle Carletti Rafael De La Barrera Francis Dessy Stefan Fernandez Robert Putnak Jean-Francois Toussaint Wellington Sun Kristen Bauer Robert V. Gibbons Bruce L. Innis

Two formulations of a new live tetravalent dengue virus (DENV) vaccine produced using re-derived master seeds from a precursor vaccine and that same precursor vaccine as a control were compared in a placebo-controlled, randomized, observer-blind, phase II trial of 86 healthy adults. Two vaccine doses were administered 6 months apart; a third dose was offered to a subset. Symptoms and signs of d...

Journal: :Pharmeuropa bio & scientific notes 2009
R Winsnes D Sesardic A Daas E Terao M-E Behr-Gross

An international collaborative study (coded BSP083) was performed under the aegis of the Biological Standardisation Programme supported by the Council of Europe and the European Commission, with the aim of replacing the in vivo challenge assays for potency determination of combined acellular pertussis (aP) vaccines by a refined procedure also allowing reduction of animal use. This study investi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید